Japanese subgroup analysis of datopotamab deruxtecan in NSCLC cohort of TROPION-PanTumor01, a phase 1 study

Shimizu, T; Kitazono, S; Garon, EB; Johnson, ML; Lisberg, A; Spira, A; Yamamoto, N; Heist, RS; Sands, JM; Meric-Bernstam, F; Zenke, Y; Yanagitani, N; Greenberg, J; Kobayashi, F; Kawasaki, Y; Yoh, K

ANNALS OF ONCOLOGY, 2022; 33 (): S476